Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Embrace2- Indicated for use as an adjunct to seizure monitoring Recalled by EMPATICA SRL Due to May have a battery life lasting less than...

Date: July 13, 2023
Company: EMPATICA SRL
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact EMPATICA SRL directly.

Affected Products

Embrace2- Indicated for use as an adjunct to seizure monitoring of adults and children age 6 and up in home or healthcare facilities during periods of rest. Models: (1) Flamingo Pink EM2-FP-S; (2) Sky Blue EM2-SB-2; (3) Seoul Grey EM2-SG-S; (4) Boston Blue EM2-BB-S; (5) Milan Black EM2-MB-S

Quantity: 1360 units

Why Was This Recalled?

May have a battery life lasting less than the full 48 hours, requiring the device to be charged more frequently.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About EMPATICA SRL

EMPATICA SRL has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report